Published online 1 November 2004
Nucleic Acids Research, Vol. 32 No. 19 © Oxford University Press 2004; all rights reserved
Quantitative sequential chromatin immunoprecipitation, a method for analyzing co-occupancy of proteins at genomic regions in vivo
Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA
* To whom correspondence should be addressed. Tel: +1 617 432 2104; Fax: +1 617 432 2529; Email: kevin{at}hms.harvard.edu
Received May 21, 2004; Revised August 29, 2004; Accepted October 11, 2004
Sequential chromatin immunoprecipitation (SeqChIP) is a procedure in which formaldehyde-crosslinked, proteinDNA complexes from living cells are subjected to two sequential immunoprecipitations with antibodies of different specificity. SeqChIP has been used to address, in a qualitative manner, whether two proteins can simultaneously co-occupy a stretch of DNA in vivo. Here, we expand on our earlier work and describe theoretical and practical considerations for performing and interpreting SeqChIP experiments in a quantitative manner. We provide a detailed experimental procedure for designing and performing SeqChIP experiments as well as experimental examples of the three possible outcomes: full co-occupancy, no co-occupancy and partial co-occupancy. In some cases of partial co-occupancy, the order of immunoprecipitations in SeqChIP can strongly influence the outcome. We experimentally confirm a quantitative parameter that provides a measure of co-occupancy of two proteins on a given region of DNA and provide information on how to interpret the results of SeqChIP experiments. Our quantitative treatment of SeqChIP data substantially expands the usefulness of the technique for elucidating molecular mechanisms in vivo.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
S. J. Burke, J. J. Collier, and D. K. Scott cAMP opposes the glucose-mediated induction of the L-PK gene by preventing the recruitment of a complex containing ChREBP, HNF4{alpha}, and CBP FASEB J, September 1, 2009; 23(9): 2855 - 2865. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Mohibullah and S. Hahn Site-specific cross-linking of TBP in vivo and in vitro reveals a direct functional interaction with the SAGA subunit Spt3 Genes & Dev., November 1, 2008; 22(21): 2994 - 3006. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Miotto and K. Struhl HBO1 histone acetylase is a coactivator of the replication licensing factor Cdt1 Genes & Dev., October 1, 2008; 22(19): 2633 - 2638. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. F. Kurland and W. P. Tansey Myc-Mediated Transcriptional Repression by Recruitment of Histone Deacetylase Cancer Res., May 15, 2008; 68(10): 3624 - 3629. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Y. Sasaki, C. F. Slemenda, P. Ghosh, T. J. Barberi, and D. L. Longo Traf1 Induction and Protection from Tumor Necrosis Factor by Nuclear Factor-{kappa}B p65 Is Independent of Serine 536 Phosphorylation Cancer Res., December 1, 2007; 67(23): 11218 - 11225. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Masui, Q. Long, T. M. Beres, M. A. Magnuson, and R. J. MacDonald Early pancreatic development requires the vertebrate Suppressor of Hairless (RBPJ) in the PTF1 bHLH complex Genes & Dev., October 15, 2007; 21(20): 2629 - 2643. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Casas-Mollano, K. van Dijk, J. Eisenhart, and H. Cerutti SET3p monomethylates histone H3 on lysine 9 and is required for the silencing of tandemly repeated transgenes in Chlamydomonas Nucleic Acids Res., February 16, 2007; 35(3): 939 - 950. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Yan, J. Jiang, C. A. Lim, Q. Wu, H.-H. Ng, and K.-C. Chin BLIMP1 regulates cell growth through repression of p53 transcription PNAS, February 6, 2007; 104(6): 1841 - 1846. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. X. Jin, A. Rabinovich, S. L. Squazzo, R. Green, and P. J. Farnham A computational genomics approach to identify cis-regulatory modules from chromatin immunoprecipitation microarray data--A case study using E2F1 Genome Res., December 1, 2006; 16(12): 1585 - 1595. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. Beres, T. Masui, G. H. Swift, L. Shi, R. M. Henke, and R. J. MacDonald PTF1 Is an Organ-Specific and Notch-Independent Basic Helix-Loop-Helix Complex Containing the Mammalian Suppressor of Hairless (RBP-J) or Its Paralogue, RBP-L Mol. Cell. Biol., January 1, 2006; 26(1): 117 - 130. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. S. Bindra, S. L. Gibson, A. Meng, U. Westermark, M. Jasin, A. J. Pierce, R. G. Bristow, M. K. Classon, and P. M. Glazer Hypoxia-Induced Down-regulation of BRCA1 Expression by E2Fs Cancer Res., December 15, 2005; 65(24): 11597 - 11604. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Blais and B. D. Dynlacht Constructing transcriptional regulatory networks Genes & Dev., July 1, 2005; 19(13): 1499 - 1511. [Abstract] [Full Text] [PDF] |
||||






